Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 35 Next »


We are planning on holding the Friday event at the Fall Meetings in Baltimore.  We will be using new functionality available through David Hay in his "Conman" tool. 

The video provides more information regarding the tool.  Please review it prior to attending the event.  We will be running the tracks as listed below. 


Clinician on FHIR Tracks

  • create accounts on conman.FHIR.org


Link to tool for Friday Baltimore meeting

http://conman.fhir.org/connectathon.html?event=baltimore2018

http://clinfhir.com/

https://fhirblog.com/

Using conMan.docx

Track 1

Care Coordination

    Lead: Emma Jones     

    Use case: Chronic Kidney Disease Use Case, 

             FHIR Resources: Care Plan and Care Team Workflow   

    Use Case workflow:  Care Plan Create, Review, Update

Care Plan as a whole and individual care plan components need to be reviewed periodically (scheduled and adhoc) to ensure that health concerns, goals, interventions defined for managing patient's conditions are appropriate over time, and that the goals are met and identified health concerns are addressed/resolved adequately.

The current CarePlan resource lacks structure(s) required to support reviews as required.

It is proposed:

  1. The FHIR Workflow Resources (ActivityDefinition, PlanDefinition) are used as consideration for creating, updating care plan/care team from use of protocols, order sets, CPG, etc.
  2. The FHIR VerificationResult Resource should be assessed/considered for its fitness-for-purpose/adequacy to support care plan reviews.

Resources involved: Required = CarePlan, CareTeam, clinicalImpression; for consideration/evaluation = VerificationResult resource 

                                Optional = PlanDefinition, ActivityDefinition

Scenario description:

Betsy Johnson has Type 2 DM diagnosed 20 years ago and started to develop chronic kidney disease (CKD) about 10 years ago. Her CKD is managed by a multi-disciplinary nephrology care team which is led by Dr Vince Jones, the Chief Nephrologist. the care team instantiated a CKD care plan to manage Betsy's chronic renal condition. 

Betsy's diabetes condition is managed by her Primary Care Physician. Her chronic renal condition is well managed and considered as relatively stable. She is seen by the nephrology care team every 2 monthly. Her CKD care plan is reviewed and intervention activities adjusted in accordance to her clinical assessment results (clinicalImpression)

    Scope: 

  •  Determine the condition (clinicalImpression)
  • Create/update carePlan, CareTeam from orderset, protocol
  • Coordinate care team to drive collaboration and coordination of care
  • SDoH as a sub track - second scenario
    • Address Barriers

Supplemental Care Plan Discussion: SDOH (Social Determinates of Health)

Scenario description addendum for SDOH

Assessing Betsy Johnson’s potential barriers to treatment compliance and healthy outcome reveals Betsy’s understanding of nutrition is oriented to diabetes management and not specifically accounting for CKD restrictions and recommendations.  Betsy no longer drives and reports that she recently moved, her new location has less public transportation options than her previous location. She is concerned about making it to her medical appointments.    

Scope

    • Review Patient Care COF definition of SDOH.
    • Determining and addressing barriers to care
    • Relationship of FHIR resources of Condition, Observation, and Clinical Impression as they related to C-CDA Concern structure currently mandated by MU2015 and implemented by systems using certified EHR products. 

Track 2

Emergency Care

     Leads: Laura Heermann and Jim McClay

     Use Case:  Screenings done during ED visit

     FHIR Resources: Questionnaire, Questionnaire Response.  

     Scope:  Entering the data for the answers to the questions contained on the screening tools such as PHQ9, Seatbelt use, Tobacco use, Alcohol use, ....

2017 San Antonio HL7 ECWG Clinon FHIR.docx

Track 3

Medications

Lead: Melva Peters, John Hatem

John Hatem email reply: will be at the event (no further details provided)

Use Case:

FHIR Resources:

Scope: 



Track 4

Clinical Impressions

    Lead: Stephen Chu, Rob Hausam 

    Use Case: (Stephen working on the use case/storyboard)

Betsy Johnson Storyboard

Scenario:

History: Betsy Johnson, a 60 yo female patients with medical history of Type 2 diabetes, hypertension, hyperlipidema 

On September 28, 2018 she attended a routine follow-up medical appointment at her Primary Care Provider's (Dr John Carlson) clinic 

Betsy complained that recently she felt a bit more tired than usual, otherwise, things seemed to be nothing remarkable

Dr Carlson reviewed Betsy's last blood work, which indicated that her eGFR was elevated beyond the normal reference range. A spot urine dipstick test revealed urine protein = 1+. Dr Carlson requested a repeat of eGFR and spot urine albumin-to-creatinine (ACR) ratio test, and told Betsy to return next week for a detailed clinical assessment on Betsy and documented the process and outcome

Clinical assessment/impression:
      • Code/description: renal/CKD assessment (no SNOMED code available)
      • Subject: Betsy Johnson; female, age 60
      • Context: PCP encounter
      • EffectiveDateTime (of clinical assessment): October 5, 2018
      • Date (documentation date): October 5, 2018
      • Investigation:
        • Reference - Observation: weight = 167 pound (75kg); height = 64 inches (162.5cm); BMI = 28.2 (overweight); BP = 148/90
        • Diagnostic report: eGFR = 62 ml/min/1.73 sq.metre (showing worse than the previous result); ACR = 68mg/g (7,68mg/mmol)
      • Protocol: e.g. 

        National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative Guideline

      • Summary
      • Finding
        • Reference - Condition: moderate chronic kidney disease
      • PrognosisCodeableConcept
      • prognosisReference
        • Reference - RiskAssessment (CKD risk progression - see diagram below)
      • Supporting information
      • Note

CKD Risk Progression assessment (Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150)

FHIR Resources:  Clinical Impression, ConditionObservation, diagnostic request, diagnostic reportsRiskAssessment; other related resources: PatientPractitionerEncounter

Scope:

To test clinical fitness-for-purpose of the ClinicalImpression resource. The usecase and scenario are defined so that the instance/contents can be reused in the CarePlan usecase of the Card Coordination track





  • No labels